CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
CervoMed Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.31+0.07 (+3.12%)
Close on Oct 19, 2026
- Market cap
- $23.66M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 17, 2023 | 1-for-1.5 reverse | Earlier per-share figures multiplied by 1.5 |
| Apr 19, 2022 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Mar 19, 2019(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Dec 14, 2018 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Nov 14, 2016(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Aug 19, 2016 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Mar 10, 2014 | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |
| Mar 7, 2014 | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |